COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.


Patient Safety Is Our Priority


KRS Global is dedicated to maintaining strict regulatory compliance, whether that be with the FDA, DEA, or State Boards of Pharmacy. Our pharmacists are licensed and where necessary, are Pharmacists in Charge for the various State Board, which require such licensure. The Pharmacy Technicians at KRS are continually trained on SOPs and the latest advances in safety and compounding.

KRS maintains all necessary product liability insurance and bonds that are required by the marketplace. Our quarterly quality assurance reports are also available upon request. According to the Compounding Quality Act, as a Registered Outsourcing Facility, KRS Global Biotechnology Inc. must meet certain conditions in order to be exempt from the FDA’s approval requirements and the requirement to label products with proper directions for use. All drugs must be compounded in compliance with cGMP (CFR-21 Manufacturing) or under the direct supervision of a licensed pharmacist in a registered facility. In addition, we must report specific information about the products that we prepare, including a list of all the products prepared during the previous six months, and information about the prepared products, such as the source of ingredients used to compound. Finally, we are required to meet other conditions such as reporting adverse events and labeling our compounded products with certain information.